Bibliometric Analysis
Journal Bibliometric Report (2021)
The Journal Bibliometric Report is based on all publications in Medline/Pubmed that were cited by Medline/Pubmed publications in 2021.
Journals for Antineoplastic Agents
For each journal, the table below lists the year of the most recent citable publication (Last Year); the total number of times citable publications were cited in 2021 (Total Cites); the average number of times citable publications from 2019 and 2020 were cited by publications in 2021 (Impact Factor); the average number of times citable publications from 2016 through 2020 were cited by publications in 2021 (5-Year Impact); the average number of times citable publications from 2021 were cited by publications in 2021 (Immediacy Index); the number of citable publications in 2021 (Articles); and the median age in years of citable publications that were cited by publications in 2021 (Cited Half-Life). Citable publications are those whose Medline/Pubmed type is "Journal Article", which in general includes things like original research, meta-analysis, and reviews, but does not include editorials or letters. The data in the table below includes self-citations.
| Rank | Journal | Last Year | Total Cites | Impact Factor | 5-Year Impact | Immediacy Index | Articles | CitedHalfLife | JournalDetails |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Anticancer Agents Med Chem | 2024 | 2415 | 1.032 | 1.160 | 0.595 | 237 | 5 | Details |
| 2 | Anticancer Drug Des | 2001 | 84 | 0.000 | 0.000 | 0.000 | 0 | 25 | Details |
| 3 | Anticancer Drugs | 2024 | 2586 | 1.351 | 1.360 | 0.794 | 141 | 7 | Details |
| 4 | Cancer Biother | 1995 | 16 | 0.000 | 0.000 | 0.000 | 0 | 27 | Details |
| 5 | Cancer Chemother Pharmacol | 2024 | 6867 | 2.039 | 2.116 | 0.484 | 161 | 8 | Details |
| 6 | Cancer Chemother Rep 2 | 1974 | 4 | 0.000 | 0.000 | 0.000 | 0 | 47 | Details |
| 7 | Cancer Chemother Rep 3 | 1974 | 9 | 0.000 | 0.000 | 0.000 | 0 | 48 | Details |
| 8 | Cancer Drug Deliv | 1987 | 15 | 0.000 | 0.000 | 0.000 | 0 | 37 | Details |
| 9 | Cancer Treat Rep | 1987 | 387 | 0.000 | 0.000 | 0.000 | 0 | 40 | Details |
| 10 | Cancer Treat Rev | 2024 | 7883 | 8.615 | 7.777 | 1.255 | 106 | 5 | Details |
| 11 | Chemioterapia | 1988 | 12 | 0.000 | 0.000 | 0.000 | 0 | 36 | Details |
| 12 | Curr Cancer Drug Targets | 2024 | 2333 | 1.719 | 2.122 | 0.672 | 61 | 8 | Details |
| 13 | Curr Med Chem Anticancer Agents | 2005 | 212 | 0.000 | 0.000 | 0.000 | 0 | 17 | Details |
| 14 | Drug Resist Updat | 2024 | 2656 | 13.068 | 11.972 | 2.381 | 21 | 5 | Details |
| 15 | Gan To Kagaku Ryoho | 2024 | 655 | 0.061 | 0.063 | 0.006 | 544 | 9 | Details |
| 16 | Invest New Drugs | 2024 | 3720 | 2.227 | 2.329 | 0.471 | 155 | 6 | Details |
| 17 | J Chemother | 2024 | 983 | 1.145 | 1.078 | 0.301 | 83 | 8 | Details |
| 18 | Mol Cancer Ther | 2024 | 16079 | 3.717 | 4.577 | 0.732 | 213 | 7 | Details |
| 19 | Sel Cancer Ther | 1991 | 4 | 0.000 | 0.000 | 0.000 | 0 | 30 | Details |